COM:BEAMTX
Beam Therapeutics
- Stock
Last Close
23.58
22/11 21:00
Market Cap
2.40B
Beta: -
Volume Today
1.16M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|
average inventory | -303.68M - | -303.68M 0% | ||||||
average payables | 4.04M - | 7.60M 88.15% | 7.08M 6.82% | 6.89M 2.63% | 8.25M 19.69% | 5.32M 35.49% | ||
average receivables | 150M - | 150M 0% | ||||||
book value per share | -0.32 - | 3.81 1,281.15% | 2.23 41.61% | 5.25 135.93% | 12.87 144.97% | 10.48 18.61% | 0.01 99.88% | |
capex per share | -0.03 - | -0.37 1,298.26% | -0.28 26.06% | -0.35 26.73% | -0.73 108.23% | -0.70 4.07% | ||
capex to depreciation | -31.45 - | -20.19 35.81% | -3.57 82.30% | -3.45 3.33% | -6.28 81.87% | -3.46 44.92% | ||
capex to operating cash flow | 0.13 - | 0.65 405.85% | 0.17 73.11% | 0.17 1.73% | 0.71 313.46% | -2.17 407.62% | ||
capex to revenue | -695.44 - | -681.54 2.00% | -0.90 99.87% | -0.80 11.01% | ||||
cash per share | 0.15 - | 4.17 2,739.77% | 2.03 51.38% | 6.41 216.44% | 21.35 232.96% | 15.40 27.88% | 0.02 99.90% | |
days of inventory on hand | ||||||||
days payables outstanding | ||||||||
days sales outstanding | 2.11K - | |||||||
debt to assets | 0.16 - | 0.22 35.72% | 0.10 56.49% | 0.13 38.19% | 0.12 11.33% | |||
debt to equity | 0.25 - | 0.41 61.43% | 0.17 57.82% | 0.24 41.74% | 0.18 27.89% | |||
dividend yield | 0.01 - | |||||||
earnings yield | -0.03 - | -0.17 430.96% | -0.09 47.24% | -0.07 27.19% | -0.07 0.77% | -0.10 44.33% | -0.00 99.93% | |
enterprise value | 240.97M - | 512.39M 112.64% | 838.14M 63.58% | 3.75B 347.82% | 4.30B 14.43% | 2.68B 37.50% | 2.10T 78,118.64% | |
enterprise value over ebitda | -32.70 - | 31.71 196.98% | -12.11 138.17% | -58.08 379.77% | -10.37 82.15% | -6.69 35.50% | -11.90K 177,838.38% | |
ev to operating cash flow | -89.02 - | -25.24 71.64% | -11.64 53.89% | -39.20 236.79% | -64.81 65.32% | 119.17 283.87% | ||
ev to sales | 46.56K - | 156.39K 235.86% | 82.84 99.95% | 44.07 46.81% | 5.56K 12,515.74% | |||
free cash flow per share | -0.24 - | -0.95 303.55% | -1.86 96.05% | -2.40 28.63% | -1.76 26.60% | -0.38 78.56% | ||
free cash flow yield | -0.01 - | -0.05 303.55% | -0.10 96.05% | -0.03 70.46% | -0.02 24.81% | -0.01 56.32% | ||
graham net net | -0.36 - | 3.23 992.93% | 0.81 74.93% | 2.00 147.28% | 10.04 401.57% | 6.71 33.16% | 0.01 99.86% | |
graham number | 2.12 - | 16.78 691.93% | 9.31 44.50% | 25.47 173.50% | 39.23 54.04% | 29.79 24.07% | 0.02 99.93% | |
income quality | 0.34 - | 0.17 48.60% | 0.92 428.69% | 0.49 46.48% | 0.18 63.66% | -0.08 143.58% | ||
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -401.89 - | -84.67 78.93% | 43.61K 51,603.56% | -22.13 100.05% | -3.78 82.91% | |||
interest debt per share | 0.57 - | 2.18 284.01% | 2.22 1.74% | 2.78 25.22% | 0.00 99.90% | |||
inventory turnover | ||||||||
invested capital | 0.25 - | 0.41 61.43% | 0.17 57.82% | 0.24 41.74% | 0.18 27.89% | |||
market cap | 242.87M - | 658.83M 171.27% | 849.84M 28.99% | 3.82B 348.94% | 5.12B 34.15% | 2.74B 46.50% | 2.10T 76,592.56% | |
net current asset value | -4.55M - | 115.29M 2,634.98% | 39.39M 65.83% | 102.20M 159.47% | 317.93M 211.07% | 484.66M 52.44% | 732.66M 51.17% | |
net debt to ebitda | 0.26 - | -9.06 3,613.24% | 0.17 101.86% | 0.96 467.31% | 1.99 107.34% | 0.13 93.26% | 1.49 1,013.73% | |
net income per share | -0.62 - | -3.28 430.96% | -1.73 47.24% | -5.49 217.04% | -5.31 3.14% | -3.76 29.17% | -0.00 99.95% | |
operating cash flow per share | -0.21 - | -0.58 176.42% | -1.59 175.00% | -2.05 28.96% | -1.03 49.64% | 0.32 131.18% | ||
payables turnover | ||||||||
receivables turnover | 0.17 - | |||||||
research and ddevelopement to revenue | 3.03K - | 4.30K 41.68% | 7.47 99.83% | 5.11 31.50% | 1.16 77.36% | |||
return on tangible assets | -3.33 - | -0.69 79.28% | -0.50 27.18% | -0.57 12.97% | -0.23 59.22% | -0.20 15.14% | -0.09 53.79% | |
revenue per share | 0.00 - | 0.00 29.32% | 0.81 157,077.64% | 0.87 7.79% | 0.00 99.44% | |||
roe | 1.91 - | -0.86 144.95% | -0.78 9.64% | -1.04 34.38% | -0.41 60.46% | -0.36 12.96% | -0.14 62.42% | |
roic | 2.00 - | -0.13 106.68% | -0.50 270.31% | -0.39 20.79% | -0.33 17.08% | -0.31 3.40% | -0.13 58.10% | |
sales general and administrative to revenue | 1.14K - | 1.23K 8.03% | 1.10 99.91% | 1.44 30.59% | 0.31 78.54% | |||
shareholders equity per share | -0.32 - | 3.81 1,281.15% | 2.23 41.61% | 5.25 135.93% | 12.87 144.97% | 10.48 18.61% | 0.01 99.88% | |
stock based compensation to revenue | 390.44 - | 640.83 64.13% | 0.84 99.87% | 1.38 64.70% | ||||
tangible asset value | -4.18M - | 134.03M 3,304.11% | 100.94M 24.68% | 245.56M 143.26% | 826.74M 236.67% | 733.47M 11.28% | 981.33M 33.79% | |
tangible book value per share | -0.32 - | 3.81 1,281.15% | 2.23 41.61% | 5.25 135.93% | 12.87 144.97% | 10.48 18.61% | 0.01 99.88% | |
working capital | -4.53M - | 122.69M 2,809.54% | 65.41M 46.69% | 205.98M 214.93% | 752.21M 265.18% | 869.30M 15.57% | 1.01B 15.67% |
All numbers in USD (except ratios and percentages)